Garry A. Nicholson
Insider Reports History
- Location
- Waltham, MA
- Signature
- /s/ Charles N. York II, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Garry A. Nicholson:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | 18 Sep 2024 | Direct |
| TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 67,000 | 30 Jun 2025 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Deferred Restricted Stock Unit (RSU) | 15,000 | 02 Jun 2025 | Direct | ||
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 14,250 | 22 Jun 2023 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Restricted Stock Unit (RSU) | 0 | 23 Apr 2026 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Stock Option (right to buy Common Stock) | 0 | 23 Apr 2026 | Direct | ||
| G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 18 Sep 2024 | Direct | ||
| Turning Point Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 17 Aug 2022 | Direct |